Skip to content

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03032250
Enrollment
35
Registered
2017-01-26
Start date
2017-05-15
Completion date
2020-04-10
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver, Malignant Head and Neck Neoplasm, Paranasal Sinus Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Lip and Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal SCC, Recurrent Paranasal Sinus Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage II Hypopharyngeal Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma, Stage III Laryngeal Squamous Cell Carcinoma, Stage III Lip and Oral Cavity Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma, Stage II Laryngeal Squamous Cell Carcinoma, Stage II Lip and Oral Cavity Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell Carcinoma, Stage IVA Hypopharyngeal Squamous Cell Carcinoma, Stage IVA Laryngeal Squamous Cell Carcinoma, Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Hypopharyngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Squamous Cell Carcinoma, Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVB Oropharyngeal Squamous Cell Carcinoma, Stage IVC Hypopharyngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Squamous Cell Carcinoma, Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVC Oropharyngeal Squamous Cell Carcinoma, Stage IV Hypopharyngeal Squamous Cell Carcinoma, Stage IV Laryngeal Squamous Cell Carcinoma, Stage IV Lip and Oral Cavity Squamous Cell Carcinoma, Stage IV Oropharyngeal Squamous Cell Carcinoma

Brief summary

This pilot clinical trial studies how well Prepare to Care kit works in improving caregiver support in patients with stage I-IV head and neck cancer that is new or has come back. Prepare to Care kit may increase knowledge about head and neck cancer and enhance stress-management skills.

Detailed description

PRIMARY OBJECTIVES: I. To assess feasibility (accrual, participation, and retention) and acceptability of a supported self-management intervention for psycho-education and stress management skills building designed for informal caregivers (intervention group n=20; waitlist control group, n=20) of head and neck cancer (HNC) patients undergoing radiotherapy (RT). II. To obtain preliminary data on caregiver intermediate (self-efficacy for \[a\] coping with cancer and \[b\] abbreviated progressive muscle relaxation) and outcome variables (burden, psychological distress, quality of life) in intervention caregivers and waitlist control caregivers at the start of radiation (T1), end of radiation (T2), and 6-weeks post-radiation (T3). III. To compare intermediate (self-efficacy for (a) coping with cancer and (b) abbreviated progressive muscle relaxation) and outcome variables (burden, psychological distress, quality of life) between intervention caregivers and waitlist control caregivers at T1, T2, and T3. IV. To obtain preliminary data on caregiver cortisol response (cortisol slope, cortisol awakening OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Caregivers watch introduction video on a digital video disc (DVD) over 10 minutes at baseline. Caregivers receive Prepare to Care kit including 8 workbook modules and complete at least 1 module over 30-45 minutes each week. Caregivers also attend interventionist session over 10-30 minutes weekly. GROUP II: Caregivers receive educational intervention as in Group I but do not attend interventionist sessions.

Interventions

OTHERCommunication Intervention

Attend interventionist sessions

Watch video on a DVD

OTHERModule completion of the Prepare to Care kit

Complete modules of the Prepare to Care kit

OTHERQuality-of-Life Assessment

Ancillary studies

OTHERSurvey Administration

Ancillary studies

OTHERSalivary cortisol collection

Obtained at three times a day (at awakening, 30 minutes post awakening and bedtime) for two consecutive days for eligible caregivers in both groups. Samples collected by placing a cotton ball under the tongue for approximately 1-2 minutes which is subsequently stored in a plastic tube and refrigerated.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

CAREGIVERS: * Providing the majority of the informal (unpaid) care during radiation therapy for a patient meeting inclusion criteria and participating in study CARE-RECIPIENTS: * Has a new or recurrent American Joint Committee on Cancer (AJCC) stage I-IV squamous cell carcinoma of the upper aerodigestive tract (including lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, and larynx cancers) * Has planned external beam radiotherapy (+/- chemotherapy) for 6-7 weeks * Has an informal (unpaid) caregiver during radiation therapy who is participating in study

Exclusion criteria

* CAREGIVERS: Has a current cancer diagnosis * CAREGIVERS: Cannot read/communicate in English * CAREGIVERS: Have an endocrine disorder (e.g., diabetes and thyroid disorders), or is currently taking a steroid based medication will not be eligible to participate in the saliva portion of the study * CARE-RECIPIENTS: Cannot read/communicate in English

Design outcomes

Primary

MeasureTime frameDescription
Self-efficacy in Coping With Cancer Caregiver InventoryAt baseline and up to the end of radiotherapy, assessed up to 1 year21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions); demonstrated validity and reliability. Minimum and maximum scores range from 10-63. Higher scores indicate higher self-efficacy in coping with cancer from the participants.
Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsSix weeks post radiation therapy10-item quantitative survey will be developed for study to assess how much caregivers liked different aspects of the intervention. Acceptability will be summarized quantitatively and qualitatively. These acceptability questions were asked only of caregivers in the intervention group - Group 1 Supportive Care (Prepare to Care Kit). All data is based on participants answering the acceptability questions as Quite a Bit/Very Much Helpful for the intervention materials. Not all participants answered this part of the outcome measure.
Accrual Assessed by Number of Caregivers Who Agreed to Participate Divided by the Number of Months of RecruitmentUp to 1 year38 patient/caregiver dyads agreed to participate, 22 months of recruitment, for accrual rate of 1.7 (caregiver) participants per month
Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Baseline and following radiotherapy, assessed up to 1 year21-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health). The CRA has been tested in cancer caregivers; demonstrated validity and reliability. Minimum and maximum scoring scale: BASELINE: Scores for esteem 15-31; lack of family support 5-15, impact of finances 3-12, impact of schedule 12-23, impact of health 11-16). AFTER RADIOTHERAPY: Scores for esteem 20-31; lack of family support 9-17, impact of finances 7-11, impact of schedule 14-22, impact of health 12-17). The higher the score the more the item being assessed impacted the participant.
Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD)Before and after radiotherapy, assessed up to 1 yearThe score is the sum of the 20 questions. Possible scoring range is 0-60. A score of 16 points or more is considered depressed.
Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)Before and after radiotherapy, assessed up to 1 year35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns). The Cqol-Canc has demonstrated validity and reliability. Minimum and maximum score at baseline is a range of 9-78 and after radiotherapy a range of 2-73. The higher the score the greater the level of change in the quality of life for participants.
Frequency of Intervention Modules Utilized Assessed by Caregiver LogsUp to 1 yearData on intervention resources used and time spent using them based on caregivers in intervention group
Number of Participants in Agreement to Perform InterventionsUp to 1 yearParticipation assessed by number of eligible participants who agreed to participate and complete study interventions.
Retention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to ParticipateUp to 1 year
Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)At baseline and up to the end of radiotherapy, assessed up to 1 yearA 3-item instrument developed for study to evaluate self-efficacy in APMR. Minimum to maximum scores range from 3-27. Higher scores demonstrate higher self efficacy in participants.

Other

MeasureTime frameDescription
Salivary Cortisol CollectionUp to 1 yearFor eligible caregivers only - collected three times a day (at awakening, 30 minutes post-awakening, and bedtime) for two consecutive days following T1 (start of radiation), T2 (end of radiation), and T3 (6 weeks post radiation). To obtain preliminary data on caregiver cortisol response (cortisol slope, cortisol awakening response, area under the curve, and intra-individual cortisol variability). Investigators will use a mixed model to evaluate differences between the groups in these parameters at times T1 and T2 and T3

Countries

United States

Participant flow

Participants by arm

ArmCount
Group I Supportive Care (Prepare to Care Kit)
Caregivers watch introduction video on a DVD over 10 minutes at baseline. Caregivers receive Prepare to Care kit including 8 workbook modules and complete at least 1 module over 30-45 minutes each week. Caregivers also attend interventionist session over 10-30 minutes weekly. Communication Intervention: Attend interventionist sessions Watch video: Watch video on a DVD Module completion of the Prepare to Care kit: Complete modules of the Prepare to Care kit Quality-of-Life Assessment: Ancillary studies Survey Administration: Ancillary studies Salivary cortisol collection: Obtained at three times a day (at awakening, 30 minutes post awakening and bedtime) for two consecutive days for eligible caregivers in both groups. Samples collected by placing a cotton ball under the tongue for approximately 1-2 minutes which is subsequently stored in a plastic tube and refrigerated.
17
Group II Control Group
Caregivers received standard of care throughout course of intervention, with option to receive study intervention at end of study. Watch video: Watch video on a DVD Module completion of the Prepare to Care kit: Complete modules of the Prepare to Care kit Quality-of-Life Assessment: Ancillary studies Survey Administration: Ancillary studies Salivary cortisol collection: Obtained at three times a day (at awakening, 30 minutes post awakening and bedtime) for two consecutive days for eligible caregivers in both groups. Samples collected by placing a cotton ball under the tongue for approximately 1-2 minutes which is subsequently stored in a plastic tube and refrigerated.
18
Total35

Baseline characteristics

CharacteristicGroup I Supportive Care (Prepare to Care Kit)TotalGroup II Control Group
Age, Continuous55.3 years
STANDARD_DEVIATION 15.5
56.4 years
STANDARD_DEVIATION 13.6
57.4 years
STANDARD_DEVIATION 11.8
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants34 Participants18 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants5 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
16 Participants29 Participants13 Participants
Region of Enrollment
United States
17 participants35 participants18 participants
Sex: Female, Male
Female
17 Participants21 Participants4 Participants
Sex: Female, Male
Male
0 Participants14 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 18
other
Total, other adverse events
0 / 170 / 18
serious
Total, serious adverse events
0 / 170 / 18

Outcome results

Primary

Accrual Assessed by Number of Caregivers Who Agreed to Participate Divided by the Number of Months of Recruitment

38 patient/caregiver dyads agreed to participate, 22 months of recruitment, for accrual rate of 1.7 (caregiver) participants per month

Time frame: Up to 1 year

Population: 38 patient/caregiver dyads agreed to participate, 22 months of recruitment, for accrual rate of 1.7 (caregiver) participants per month

ArmMeasureValue (NUMBER)
Group I Supportive Care (Prepare to Care Kit)Accrual Assessed by Number of Caregivers Who Agreed to Participate Divided by the Number of Months of Recruitment1.7 participants/months
Primary

Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)

21-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health). The CRA has been tested in cancer caregivers; demonstrated validity and reliability. Minimum and maximum scoring scale: BASELINE: Scores for esteem 15-31; lack of family support 5-15, impact of finances 3-12, impact of schedule 12-23, impact of health 11-16). AFTER RADIOTHERAPY: Scores for esteem 20-31; lack of family support 9-17, impact of finances 7-11, impact of schedule 14-22, impact of health 12-17). The higher the score the more the item being assessed impacted the participant.

Time frame: Baseline and following radiotherapy, assessed up to 1 year

Population: Not all participants submitted information after completion of radiotherapy.

ArmMeasureGroupValue (MEAN)Dispersion
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Esteem at baseline25.98 score on a scaleStandard Deviation 3.6
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Lack of family support at baseline11.29 score on a scaleStandard Deviation 2.69
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on finances at baseline8.29 score on a scaleStandard Deviation 2.28
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Esteem after radiotherapy25.75 score on a scaleStandard Deviation 3.31
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on schedule at baseline17.35 score on a scaleStandard Deviation 3.31
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on health at baseline13.94 score on a scaleStandard Deviation 1.48
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Lack of family support after radiotherapy12.58 score on a scaleStandard Deviation 2.23
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on finances after radiotherapy8.42 score on a scaleStandard Deviation 1.16
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on schedule after radiotherapy18.33 score on a scaleStandard Deviation 2.74
Group I Supportive Care (Prepare to Care Kit)Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on health after radiotherapy14.33 score on a scaleStandard Deviation 1.61
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on health after radiotherapy14.38 score on a scaleStandard Deviation 1.59
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Esteem at baseline25.88 score on a scaleStandard Deviation 3.8
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on schedule at baseline16.78 score on a scaleStandard Deviation 4.1
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on health at baseline13.67 score on a scaleStandard Deviation 1.65
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Esteem after radiotherapy25.30 score on a scaleStandard Deviation 4.19
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Lack of family support at baseline11.25 score on a scaleStandard Deviation 2.67
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Lack of family support after radiotherapy11.19 score on a scaleStandard Deviation 3.23
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on finances at baseline8.89 score on a scaleStandard Deviation 1.78
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on schedule after radiotherapy16.56 score on a scaleStandard Deviation 4.43
Group II No Interventionist SessionsChange in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)Impact on finances after radiotherapy8.25 score on a scaleStandard Deviation 1.24
Primary

Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD)

The score is the sum of the 20 questions. Possible scoring range is 0-60. A score of 16 points or more is considered depressed.

Time frame: Before and after radiotherapy, assessed up to 1 year

Population: Not all participants completed this intervention after radiotherapy timeframe indicated for this outcome measure

ArmMeasureGroupValue (MEAN)Dispersion
Group I Supportive Care (Prepare to Care Kit)Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD)Score at baseline19.71 score on a scaleStandard Deviation 13.05
Group I Supportive Care (Prepare to Care Kit)Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD)Score after radiotherapy19.00 score on a scaleStandard Deviation 15.66
Group II No Interventionist SessionsChange in Psychological Distress - Center for Epidemiological Studies Depression (CESD)Score at baseline19.28 score on a scaleStandard Deviation 12.97
Group II No Interventionist SessionsChange in Psychological Distress - Center for Epidemiological Studies Depression (CESD)Score after radiotherapy13.58 score on a scaleStandard Deviation 8.65
Primary

Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)

35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns). The Cqol-Canc has demonstrated validity and reliability. Minimum and maximum score at baseline is a range of 9-78 and after radiotherapy a range of 2-73. The higher the score the greater the level of change in the quality of life for participants.

Time frame: Before and after radiotherapy, assessed up to 1 year

Population: Not all participants completed this intervention after radiotherapy as indicated for this outcome measure.

ArmMeasureGroupValue (MEAN)Dispersion
Group I Supportive Care (Prepare to Care Kit)Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)At baseline87.63 score on a scaleStandard Deviation 25.95
Group I Supportive Care (Prepare to Care Kit)Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)After radiotherapy92.55 score on a scaleStandard Deviation 22.09
Group II No Interventionist SessionsChange in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)At baseline87.26 score on a scaleStandard Deviation 20.32
Group II No Interventionist SessionsChange in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)After radiotherapy89.86 score on a scaleStandard Deviation 18.78
Primary

Frequency of Intervention Modules Utilized Assessed by Caregiver Logs

Data on intervention resources used and time spent using them based on caregivers in intervention group

Time frame: Up to 1 year

ArmMeasureGroupValue (MEAN)Dispersion
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsCancer Education22.3 MinutesStandard Deviation 10.2
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsUtilizing Resources38.7 MinutesStandard Deviation 20.1
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsSeeking/ Accepting Support55.2 MinutesStandard Deviation 27.8
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsCommunicating with others40.3 MinutesStandard Deviation 12.7
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsManaging Time40.8 MinutesStandard Deviation 26.9
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsCoping66.7 MinutesStandard Deviation 51.1
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsPracticing Healthy Behaviors48 MinutesStandard Deviation 15.6
Group I Supportive Care (Prepare to Care Kit)Frequency of Intervention Modules Utilized Assessed by Caregiver LogsRelaxation CD58 MinutesStandard Deviation 18.1
Primary

Number of Participants in Agreement to Perform Interventions

Participation assessed by number of eligible participants who agreed to participate and complete study interventions.

Time frame: Up to 1 year

Population: 90 eligible patient/caregiver dyads, 38 agreed to participate

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Group I Supportive Care (Prepare to Care Kit)Number of Participants in Agreement to Perform Interventions38 Participants
Primary

Number of Participants Noting Quite a Bit/Very Much Helpful to Survey Questions

10-item quantitative survey will be developed for study to assess how much caregivers liked different aspects of the intervention. Acceptability will be summarized quantitatively and qualitatively. These acceptability questions were asked only of caregivers in the intervention group - Group 1 Supportive Care (Prepare to Care Kit). All data is based on participants answering the acceptability questions as Quite a Bit/Very Much Helpful for the intervention materials. Not all participants answered this part of the outcome measure.

Time frame: Six weeks post radiation therapy

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsWeekly email reminders4 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsStudy website0 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsUtilizing Resources workbook7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsManaging Time workbook7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsMuscle Relaxation workbook7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsIntroductory DVD4 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsMeetings with study interventionist6 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsRelaxation CD7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsWeekly text reminders6 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsClinic iPads0 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsCancer Education workbook9 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsSeeking/Accepting Support workbook7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsCommunicating with Others workbook7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsHealthy Behaviors workbook7 Participants
Group I Supportive Care (Prepare to Care Kit)Number of Participants Noting Quite a Bit/Very Much Helpful to Survey QuestionsPositive Coping workbook7 Participants
Primary

Retention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to Participate

Time frame: Up to 1 year

Population: 38 agreed to participate (19 in caregiver intervention group, 19 in caregiver control group)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Group I Supportive Care (Prepare to Care Kit)Retention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to Participate12 Participants
Group II No Interventionist SessionsRetention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to Participate16 Participants
Primary

Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)

A 3-item instrument developed for study to evaluate self-efficacy in APMR. Minimum to maximum scores range from 3-27. Higher scores demonstrate higher self efficacy in participants.

Time frame: At baseline and up to the end of radiotherapy, assessed up to 1 year

ArmMeasureGroupValue (MEAN)Dispersion
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)At baseline11.88 score on a scaleStandard Deviation 6.53
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)After radiotherapy16.08 score on a scaleStandard Deviation 2.68
Group II No Interventionist SessionsSelf-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)At baseline13.33 score on a scaleStandard Deviation 5.36
Group II No Interventionist SessionsSelf-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)After radiotherapy12.19 score on a scaleStandard Deviation 5.59
Primary

Self-efficacy in Coping With Cancer Caregiver Inventory

21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions); demonstrated validity and reliability. Minimum and maximum scores range from 10-63. Higher scores indicate higher self-efficacy in coping with cancer from the participants.

Time frame: At baseline and up to the end of radiotherapy, assessed up to 1 year

ArmMeasureGroupValue (MEAN)Dispersion
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryManaging medical information at baseline22.35 score on a scaleStandard Deviation 3.26
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryCaring for care recipient at baseline52.94 score on a scaleStandard Deviation 9.65
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryCaring for oneself at baseline25.71 score on a scaleStandard Deviation 10.44
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryManaging difficult interactions/emotions at baseline34.52 score on a scaleStandard Deviation 10.96
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryManaging medical information after radiotherapy23.08 score on a scaleStandard Deviation 2.54
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryCaring for care recipient after radiotherapy54.42 score on a scaleStandard Deviation 5.62
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryCaring for oneself after radiotherapy25.75 score on a scaleStandard Deviation 9.4
Group I Supportive Care (Prepare to Care Kit)Self-efficacy in Coping With Cancer Caregiver InventoryManaging difficult interactions/emotions after radiotherapy37.92 score on a scaleStandard Deviation 10.03
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryManaging difficult interactions/emotions after radiotherapy39.68 score on a scaleStandard Deviation 7.86
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryManaging medical information at baseline22.00 score on a scaleStandard Deviation 3.29
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryManaging medical information after radiotherapy22.43 score on a scaleStandard Deviation 4.8
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryCaring for care recipient at baseline55.11 score on a scaleStandard Deviation 6.11
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryCaring for oneself after radiotherapy31.30 score on a scaleStandard Deviation 8.26
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryCaring for oneself at baseline28.06 score on a scaleStandard Deviation 7.83
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryCaring for care recipient after radiotherapy54.98 score on a scaleStandard Deviation 6.82
Group II No Interventionist SessionsSelf-efficacy in Coping With Cancer Caregiver InventoryManaging difficult interactions/emotions at baseline39.13 score on a scaleStandard Deviation 7.95
Other Pre-specified

Salivary Cortisol Collection

For eligible caregivers only - collected three times a day (at awakening, 30 minutes post-awakening, and bedtime) for two consecutive days following T1 (start of radiation), T2 (end of radiation), and T3 (6 weeks post radiation). To obtain preliminary data on caregiver cortisol response (cortisol slope, cortisol awakening response, area under the curve, and intra-individual cortisol variability). Investigators will use a mixed model to evaluate differences between the groups in these parameters at times T1 and T2 and T3

Time frame: Up to 1 year

Population: Analysis of this outcome measure is currently incomplete and cannot be reported as this time as the information is not available.

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026